Cooperation with the MED-UNI in Innsbruck is working

Together with the Institute of Pharmacy at the Leopold-Franzens University of Innsbruck, the basis for the two most essential research topics considered as USP is being developed in a project funded by the Province of Tyrol. The basis for any approval as a medical device is the scientifically substantiated evidence regarding efficacy and toxicity. Thus, as a preliminary stage to the required clinical tests, the basis is created by means of well-founded evidence in order to be able to enter into the clinical studies together with a financially strong partner.

Prof. Dr. Andreas Bernkop-Schnürch, who is one of the top 5 scientists in the world in the field of nano-drug targeting, has been won as a research partner.

What makes this cooperation special is the fact that with this partner not only the best research competence is involved in the project, but also the contacts to the pharmaceutical companies of this world are given, which are essential for the desired exit.

Furthermore, with MED-UNI in Innsbruck, another partner is available to plan and carry out the preliminary clinical studies as soon as the scientific basis has been confirmed. For this purpose, the first discussions are already taking place, in order to then get into the implementation as quickly as possible.